adenosine monophosphate has been researched along with Cerebromeningitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bannister, R; Cihlar, T; Cronin, J; de Wit, E; Feldmann, F; Feldmann, H; Gary, JM; Jordan, R; Klena, JD; Lo, MK; Nichol, ST; Patel, NR; Spiropoulou, CF; Zaki, SR | 1 |
Bell, DJ; Bhagani, S; Cropley, I; Filipe, A; Gifford, RJ; Gopal, R; Hopkins, S; Hughes, J; Jabeen, F; Jacobs, M; Johannessen, I; Karageorgopoulos, D; Lackenby, A; Lester, R; Liu, RS; MacConnachie, A; Mahungu, T; Marshall, N; Martin, D; Mepham, S; Orton, R; Palmarini, M; Patel, M; Perry, C; Peters, SE; Porter, D; Ritchie, D; Ritchie, ND; Rodger, A; Seaton, RA; Sreenu, VB; Templeton, K; Thomson, EC; Warren, S; Wilkie, GS; Zambon, M | 1 |
2 other study(ies) available for adenosine monophosphate and Cerebromeningitis
Article | Year |
---|---|
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.
Topics: Adenosine Monophosphate; Alanine; Animals; Brain; Chlorocebus aethiops; Female; Henipavirus Infections; Male; Meningoencephalitis; Neutralization Tests; Nipah Virus; Viremia; Virus Replication | 2019 |
Late Ebola virus relapse causing meningoencephalitis: a case report.
Topics: Acute Disease; Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Cranial Nerve Diseases; Disease Outbreaks; Drugs, Investigational; Ebolavirus; Female; Genome, Viral; Hemorrhagic Fever, Ebola; Humans; Meningoencephalitis; Nurses; Radiculopathy; Recurrence; Ribonucleotides; RNA, Viral; Scotland; Sierra Leone; Viral Load | 2016 |